Dr Reddy’s Q2 Net Falls 17%, Stock Down 2%

Sharemasterindia.com: Dr Reddy’s Laboratories, India’s second-largest drugmaker by revenue, reported a 17 per cent drop in its second-quarter profit, pushing its shares down over two per cent.
The company, whose formulations include drugs for cardiovascular disorders, oncology and pain management, posted a net profit of rupee“>Rs. 574 crore compared with Rs. 690 crore a year earlier.
As of 12.48 p.m. Dr Reddy’s shares traded 1.9 per cent lower at Rs. 3,023 underperforming the Nifty which was up 0.4 per cent.Read More....